Favrille, Inc.

(NASDAQ:FVRL)

0.085

-0.015 (-15.00%)

Jan 08 - Close

Open
0.100
High
0.100
Low
0.081
Vol.
913.10K
Mkt Cap
4.13M
52Wk High
2.15
52Wk Low
0.01
Avg. Vol.
560.80K
P/E (Trailing)
-0.07
Beta
0.00
Short %
Div. Yield

Company Profile

Favrille, Inc.

4401 Eastgate Mall

San Diego, CA 92121

United States - Map

Phone: (858) 526-8000

Fax: (858) 677-0800

Website: www.favrille.com

State of incorporation: Delaware

CEO: Dr. John P. Longenecker, Ph.D.

Employees: 155

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

biopharmaceutical company for cancer treatment

A biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system.

Members owning FVRL also own

QLD (50.00%), UYG (50.00%), FMCN (50.00%), SOHU (50.00%), BAC (50.00%)

Member sentiment (?)    Neutral

Top members owning FVRL

* Average monthly return vs. S&P 500

Recent opinions on FVRL

No recent Opinions for FVRL